Peptides are short chains of amino acids — the building blocks of proteins. They act as signaling molecules in the body, influencing processes like hormone release, tissue repair, immune function, and metabolism. Compounded peptide therapies use synthetic versions of naturally occurring peptides to support specific health outcomes under medical supervision.

Yes. Compounding of peptide therapies is authorized under RA 8293 Section 72.4 of the Intellectual Property Code of the Philippines when prepared by an FDA-licensed pharmacy on an individual prescription basis. Every peptide compound prepared by ObraRx requires a valid prescription from a PRC-licensed physician and is prepared under full regulatory compliance with RA 9711 (FDA Act) and RA 10918 (Philippine Pharmacy Act). Note: the PCP advisory from March 2026 warning against unregistered gray market peptides specifically targets unlicensed sellers — a licensed, LTO-holding sterile compounding pharmacy operating under USP <797> is the solution to that problem, not its target.

NAD+ is a coenzyme essential to cellular energy production and DNA repair. Research shows NAD+ levels decline significantly with age, and this decline is associated with reduced cellular function, lower energy, impaired recovery, and accelerated aging processes. NAD+ supplementation aims to restore these levels to support healthier aging.

Yes. Under RA 10918 Section 30, all compounding and dispensing must be performed by a duly registered and licensed pharmacist, and all prescription drugs require a valid prescription. ObraRx does not sell peptides over the counter or without a prescription.